0000899243-18-022726.txt : 20180817
0000899243-18-022726.hdr.sgml : 20180817
20180817174455
ACCESSION NUMBER: 0000899243-18-022726
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180807
FILED AS OF DATE: 20180817
DATE AS OF CHANGE: 20180817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pillar Invest Corp
CENTRAL INDEX KEY: 0001534428
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 181026704
BUSINESS ADDRESS:
STREET 1: C/O PILLAR INVEST OFFSHORE SAL
STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
BUSINESS PHONE: 0119611363362
MAIL ADDRESS:
STREET 1: C/O PILLAR INVEST OFFSHORE SAL
STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pillar Pharmaceuticals I LP
CENTRAL INDEX KEY: 0001534425
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 181026705
BUSINESS ADDRESS:
STREET 1: C/O PILLAR INVEST OFFSHORE SAL
STREET 2: STARCO CENTER BLOC B FL3, OMAR DAOUK ST
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
BUSINESS PHONE: 0119611363362
MAIL ADDRESS:
STREET 1: C/O PILLAR INVEST OFFSHORE SAL
STREET 2: STARCO CENTER BLOC B FL3, OMAR DAOUK ST
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pillar Pharmaceuticals II, L.P.
CENTRAL INDEX KEY: 0001562069
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 181026706
BUSINESS ADDRESS:
STREET 1: STARCO CENTER BLOC B, THIRD FLOOR
STREET 2: OMAR DAOUK STREET
CITY: BEIRUT 2020-3313
STATE: M8
ZIP: 2020-3313
BUSINESS PHONE: 9611363362
MAIL ADDRESS:
STREET 1: STARCO CENTER BLOC B, THIRD FLOOR
STREET 2: OMAR DAOUK STREET
CITY: BEIRUT 2020-3313
STATE: M8
ZIP: 2020-3313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pillar Pharmaceuticals III, L.P.
CENTRAL INDEX KEY: 0001576891
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 181026707
BUSINESS ADDRESS:
STREET 1: STARCO CENTER, BLOC B, THIRD FLOOR
STREET 2: OMAR DAOUK STREET
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
BUSINESS PHONE: 961 1 363 362
MAIL ADDRESS:
STREET 1: STARCO CENTER, BLOC B, THIRD FLOOR
STREET 2: OMAR DAOUK STREET
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000861838
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043072298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 167 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6176795500
MAIL ADDRESS:
STREET 1: 167 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: HYBRIDON INC
DATE OF NAME CHANGE: 19951211
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-07
1
0000861838
IDERA PHARMACEUTICALS, INC.
IDRA
0001534428
Pillar Invest Corp
C/O IDERA PHARMACEUTICALS, INC.
167 SIDNEY STREET
CAMBRIDGE
MA
02139
0
0
1
0
0001534425
Pillar Pharmaceuticals I LP
PILLAR INVEST OFFSHORE SAL, STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
0
0
1
0
0001562069
Pillar Pharmaceuticals II, L.P.
PILLAR INVEST OFFSHORE SAL, STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
0
0
1
0
0001576891
Pillar Pharmaceuticals III, L.P.
PILLAR INVEST OFFSHORE SAL STARCO CTR,
BLOC B, 3RD FLOOR OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
0
0
1
0
Common Stock
2018-08-07
4
S
0
91893
5.551
D
0
I
See Footnote
Common Stock
2018-08-07
4
S
0
75000
5.6229
D
0
I
See Footnote
Common Stock
2018-08-08
4
S
0
8107
5.8911
D
0
I
See Footnote
Common Stock
2018-08-08
4
S
0
50000
5.8838
D
0
I
See Footnote
Common Stock
2018-08-08
4
S
0
20000
5.975
D
0
I
See Footnote
Common Stock
2018-08-09
4
S
0
15000
6.2508
D
0
I
See Footnote
Common Stock
2018-08-09
4
S
0
25000
6.2943
D
0
I
See Footnote
Common Stock
2018-08-09
4
S
0
15000
6.3549
D
0
I
See Footnote
The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $5.4000-$5.7509. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Shares sold by Pillar Pharmaceuticals II, L.P. ("Pillar II"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. Following this transaction, Pillar II owns directly 697,092 shares of common stock of the Issuer.
The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $5.3800-$5.8000. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Shares sold by Participations Besancon. Participations Besancon is a fund advised by Pillar GP. Pillar GP disclaims Section 16 beneficial ownership of the Besancon Warrants and the common stock underlying such warrants and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, resulting from fees payable to Pillar GP in its capacity as investment advisor to Besancon. Following this transaction, Participations Besancon owns directly 1,061,212 shares of common stock of the Issuer.
The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $5.8300-$6.0000. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Shares sold by Pillar II. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. Following this transaction, Pillar II owns directly 688,985 shares of common stock of the Issuer.
The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $5.6300-$6.1100. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Shares sold by Pillar Pharmaceuticals III, L.P. ("Pillar III"). Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar III and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar III. Following this transaction, Pillar III owns directly 308,980 shares of common stock of the Issuer.
The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $5.9500-$6.0000. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Shares sold by Pillar Pharmaceuticals I, L.P. ("Pillar I"). Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar I and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar I. Following this transaction, Pillar I owns directly 241,266 shares of common stock of the Issuer.
The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $6.1600-$6.3200. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Shares sold by Pillar II. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. Following this transaction, Pillar II owns directly 673,985 shares of common stock of the Issuer.
The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $6.1600-$6.4300. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Shares sold by Pillar I. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar I and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar I. Following this transaction, Pillar I owns directly 216,266 shares of common stock of the Issuer.
The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $6.3000-$6.4000. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Shares sold by Pillar III. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar III and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar III. Following this transaction, Pillar III owns directly 293,980 shares of common stock of the Issuer.
Pillar Invest Corporation, /s/ Youssef El Zein, Authorized Person
2018-08-17